The Mounjaro jab: what it does, how it works and what to expect

Step 1: understanding what the jab actually does in your body

Tirzepatide (the medicine inside the Mounjaro jab) mimics two hormones your gut releases after eating: GIP and GLP-1. Both play a role in telling your brain you're full and in slowing the rate at which food leaves your stomach. Mounjaro activates both receptors at once, which is why it is sometimes described as a dual-agonist. No other weight-loss injection licensed in the UK shares that mechanism.

The practical result is that appetite falls, meals feel more satisfying, and many people find their interest in between-meal snacking drops naturally. None of this happens overnight. The dose escalation schedule exists precisely so your body has time to adapt at each level before the prescriber considers moving you up. The full clinical picture of tirzepatide covers the mechanism in more detail if you want to read further.

In the SURMOUNT-1 trial, involving 2,539 adults with obesity and no diabetes over 72 weeks, participants on 15mg tirzepatide achieved an average body-weight reduction of around 20–21%, as published in the New England Journal of Medicine. Results in real-world use will vary, and a prescriber is the right person to discuss what reasonable expectations look like for you individually.

Step 2: preparing and giving yourself the jab

The Mounjaro KwikPen is pre-filled and pre-set to the right dose — there is no drawing up of liquid, no dial to turn. Each pen contains four doses, one per week. Before your first injection, your prescriber or the patient information leaflet will walk you through the technique; our Mounjaro injection guide also covers the process visually.

In brief: choose an injection site on your abdomen, thigh or upper arm, and rotate around those sites from week to week to avoid irritation. Clean the skin, attach a fresh needle, press the pen against the skin, press the button and hold it in place until the injection is complete. The guide to Mounjaro injection sites goes through exactly where and how to rotate safely.

Timing is flexible, the same day each week is the aim, but if you miss a day it is not the end of the world. Always check the patient information leaflet rather than acting on general advice, and raise any questions with your prescriber. Most people find attaching the injection to a fixed weekly routine helps: Sunday evenings after dinner, for example, or just before putting the pen back in the fridge door where it lives between doses.

Step 3: storage, eligibility and cost context

The pen stays refrigerated at 2–8°C between uses. There is a limited window during which it can be kept at room temperature for travel or convenience, but the exact duration is set out in the SmPC and patient information leaflet, always refer there rather than to general estimates online. For more on travelling with the pen, the Mounjaro tips and tricks page covers practical day-to-day questions.

Eligibility for the Mounjaro jab as a licensed UK treatment covers adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. A prescriber assesses the whole picture, so BMI alone is not the deciding factor. If you want to understand whether the NHS route or a private route suits your situation, the weight-loss jab overview sets out both paths clearly.

Private treatment costs vary by dose and provider. For a factual overview of what is typically included and what to look for, the Mounjaro pricing page gives an honest breakdown. The NHS tirzepatide medicines page is also worth reading for an independent, plain-English summary of the medicine.

Step 4: side effects to be aware of before you start

The most frequently reported side effects of the Mounjaro jab are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion and burping. These are most noticeable in the first week or two at a new dose level and usually ease as your body settles. Headache, fatigue, dizziness and mild injection-site reactions are also reported.

Rarer but more serious effects include acute pancreatitis. Get urgent medical help for severe stomach pain that does not pass, especially if it radiates to your back, with or without vomiting. The fat jab guide covers the side-effect picture in more depth, and the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk lets you report anything unexpected directly to the UK's medicines regulator.

Mounjaro is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for use in people under 18. Women using oral contraceptive pills should discuss with their prescriber whether to add a non-oral method during the first four weeks of treatment and the four weeks after each dose increase, because tirzepatide may reduce pill absorption. These are all things a prescriber will cover during your clinical assessment. When you feel ready, you can check your eligibility through a free consultation with our clinical team.